Advance Search

Correlation Between Immunohistochemical Expression of Epstein-Barr Virus Latent Membrane Protein-1 (LMP-1) and Clinical Stages of Sinonasal Carcinoma

DOI: https://doi.org/10.20956/nmsj.v7i2.20037
Article History

Submited : February 15, 2022
Published : October 21, 2022

Introduction: Sinonasal tumors are rarely found. The protected nature of the sinuses makes early detection of tumors growing in these areas difficult. The Epstein-Barr virus is one of the most common viruses found in humans; which expresses Latent Membrane Protein-1 (LMP-1) that can transform cell lines and alter cell phenotype due to its oncogenic potential. Objective: To investigate the relationship between immunohistochemical expression of Latent Membrane Protein-1 (LMP-1) from Epstein-Barr virus and clinical stages of sinonasal carcinoma. Methods: This cross-sectional study was carried out in DR. Wahidin Sudirohusodo General Hospital and anatomic pathology of Hasanuddin University Hospital, Makassar, South Sulawesi, Indonesia, from October 2016 to March 2017. Histopathological samples from biopsy specimen of all subjects diagnosed with sinonasal carcinoma in Otorhinolaryngology-Head and Neck Surgery outpatient clinic were taken and examined for LMP-1 expression using immunohistochemical staining. The samples were taken from paraffin block from patients. Result: There were 33 males (67.3%) and 16 females (32.7%) with sinonasal carcinoma who participated in this study. The majority of participants aged ≥50 years (25 people, 51.0%) and worked as farmers (27 people, 55.1%). A significant correlation between LMP-1 expression and sinonasal carcinoma clinical stages was found (Spearman’s correlation r = 0.355 and p <0.001). Conclusion: Higher LMP-1 expression correlates with higher sinonasal carcinoma clinical stage in patients aged <50 years.

References

  1. Ballenger JJ. Tumor Hidung dan Sinus Paranasal dalam Penyakit Telinga, Hidung, Tenggorok, Kepala dan Leher. Jakarta: Bina Rupa Aksara; 1994.
  2. Soepardi EA, Iskandar N, Bashiruddin J, Restuti RD. Tumor Hidung dan Sinonasal. In: Roezin A, Armiyanto, editors. Buku Ajar Ilmu Kesehatan Telinga Hidung Tenggorok Jakarta: Balai Penerbit FKUI; 2007. p. 178-81.
  3. Bailey BJ, Calhoun KH. Sinonasal Anatomy and Physiology. In: Leung RM, Walsh WE, Kern RC, editors. Atlas of Head and Neck Surgery-Otolaryngology. New York: Lippincott William & Wilkin; 2006. p. 359-69.
  4. Cardesa A, Zidar N, Nadal A. Pathology and Genetics of Head and Neck Tumours. In: Kleihues P, Sobin LH, EL B, editors. World Health Organization Classification of Tumours. Lyon: IARC Press; 2005. p. 126.
  5. Bastiana, Kuhuwael FG. Perbandingan Kasus Kanker Kepala Leher dalam Dua Dekade di Makassar. Konas PERHATI XV; 5-7 July; Makassar. Makassar2010.
  6. Ali AS, Al-Shraim M, Al-Hakami AM, Jones IM. Epstein-Barr virus: clinical and epidemiological revisits and genetic basis of oncogenesis. The open virology journal. 2015;9:7.
  7. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10(3):803-21.
  8. Carrillo-Infante C, Abbadessa G, Bagella L, Giordano A. Viral infections as a cause of cancer. Int J Oncol. 2007;30(6):1521-8.
  9. Zheng H, Li LL, Hu DS, Deng XY, Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007;4(3):185-96.
  10. Hu L, Troyanovsky B, Zhang X, Trivedi P, Ernberg I, Klein G. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. Cancer Res. 2000;60(19):5589-93.
  11. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. The Journal of molecular diagnostics. 2008;10(4):279-92.
  12. Hariwiyanto B. Ekspresi LMP1 EBV pada keberhasilan terapi dan tiga tahun ketahanan hidup penderita karsinoma nasofaring [Master]. Yogyakarta: Gajah Mada University; 2009.
  13. Meckes Jr D, Raab-Traub N. Mining Epstein-Barr virus LMP1 signaling networks. J Carcinogene Mutagene S. 2011;11(1):37-9.
  14. Lopategui JR, Gaffey MJ, Frierson Jr HF, Chan J, Mills SE, Chang KL, et al. Detection of Epstein-Barr viral RNA in sinonasal undifferentiated carcinoma from Western and Asian patients. The American journal of surgical pathology. 1994;18(4):391-8.
  15. Kutok J, Wang F. Spectrum of Epstein-Barr virus–associated diseases. Annu Rev Pathol Mech Dis. 2006;1:375-404.
  16. Leung SY, Yuen ST, Chung LP, Kwong WK, Wong MP, Chan SY. Epstein-Barr virus is present in a wide histological spectrum of sinonasal carcinomas. The American journal of surgical pathology. 1995;19(9):994-1001.
  17. Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurgery Clinics. 2013;24(1):39-49.
  18. Shavilla E, Aroeman NA, Dewi YA, Permana AD. Prevalensi Kanker Sinonasal di Poliklinik THT-KL RS. Hasan Sadikin Bandung, Januari 2013-Juli 2015. Tunas Medika Jurnal Kedokteran & Kesehatan. 2016;3(1):5-9.
  19. Binazzi A, Ferrante P, Marinaccio A. Occupational exposure and sinonasal cancer: a systematic review and meta-analysis. BMC Cancer. 2015;15(1):1-17.
  20. Poursadegh M, Poursadegh F, Esmaeili M, Bakhshaee M. Epidemiological survey of sinonasal malignancy in North-East Iran. Iran J Otorhinolaryngol. 2015;27(80):225.
  21. Santoso OD. Infeksi Epstein-Barr Virus (EBV) Sebagai Salah Satu Faktor Risiko Terjadinya Karsinoma Sinonasal (EBV Infection as A Risk Factor for Sinonasal Carcinoma). Yogyakarta: Universitas Gadjah Mada; 2011.
  22. Zeng M, Chen Y, Jia X, Liu Y. The anti-apoptotic role of EBV-LMP1 in lymphoma cells. Cancer Manag Res. 2020;12:8801.
  23. Atikah A, Sadhana U, Miranti IP, Puspasari D, Karlowee V. Effect of LMP-1 and mutant p53 on the Prognosis of Undifferentiated Type of Nasopharyngeal Carcinoma. Mutiara Medika: Jurnal Kedokteran dan Kesehatan. 2022;22(1):57-68.
  24. Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol. 2012;65(1):41-5.
  25. Punagi AQ, Mubarika S, Yusuf I. Vascular Endothelial Growth Factor Receptor (VEGFR Flt-4) and Latent Membrane Protein (LMP-1) Expression in Nasopharyngeal Carcinoma. The Open Otorhinolaryngology Journal. 2013;7(1).
Dewi, L. R., Akil, M. A., Savitri, E., & Punagi, A. (2022). Correlation Between Immunohistochemical Expression of Epstein-Barr Virus Latent Membrane Protein-1 (LMP-1) and Clinical Stages of Sinonasal Carcinoma. Nusantara Medical Science Journal, 7(2), 79-87. https://doi.org/10.20956/nmsj.v7i2.20037

Copyright (c) 2022 Array

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.
Fulltext
PDF